| Nov 28, 2025 |
Dec 2, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
22.5
|
-5,970
|
-11.74%
|
✓
|
$905.9K |
| Feb 13, 2025 |
Feb 14, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
38.8
|
-2,154
|
-2.38%
|
✓
|
$251.4K |
| Feb 8, 2025 |
Feb 12, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
41.3
|
-980
|
-2.24%
|
✓
|
$115.9K |
| Jan 31, 2025 |
Feb 4, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
41.3
|
-1,207
|
-2.80%
|
✓
|
$184.6K |
| Apr 15, 2024 |
Apr 17, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
15.0
|
-19,818
|
-19.55%
|
✓
|
$2.6M |
| Mar 14, 2024 |
Mar 15, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
2.5
|
-75,000
|
-47.91%
|
✓
|
$10.5M |
| Feb 28, 2024 |
Feb 29, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
2.5
|
-75,000
|
-48.01%
|
✓
|
$10.1M |
| Feb 13, 2024 |
Feb 15, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
41.3
|
-1,098
|
-2.63%
|
✓
|
$146.1K |
| Feb 6, 2024 |
Feb 8, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
38.8
|
-2,260
|
-2.80%
|
✓
|
$313.4K |
| Jan 31, 2024 |
Feb 2, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
37.5
|
-1,207
|
-3.11%
|
✓
|
$169.9K |
| Aug 21, 2023 |
Aug 23, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
37.5
|
-1,600
|
-4.21%
|
✓
|
$171.8K |
| Feb 6, 2023 |
Feb 8, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
15.0
|
-19,650
|
-15.71%
|
✓
|
$2M |
| Jan 31, 2023 |
Feb 2, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
32.5
|
-1,207
|
-6.73%
|
✓
|
$132.7K |
| Jan 6, 2023 |
Jan 10, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
41.3
|
-400
|
-2.49%
|
✓
|
$50K |
| Nov 30, 2022 |
Dec 1, 2022 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
3.8
|
-50,000
|
-51.58%
|
✓
|
$6.3M |
| Nov 8, 2022 |
Nov 10, 2022 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
5.0
|
-24,693
|
-44.11%
|
✓
|
$3.1M |
| Nov 2, 2022 |
Nov 4, 2022 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
10.0
|
-9,368
|
-23.04%
|
✓
|
$1.2M |
| Oct 17, 2022 |
Oct 19, 2022 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
12.5
|
-4,960
|
-24.07%
|
✓
|
$549.7K |
| Feb 7, 2022 |
Feb 9, 2022 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
30.0
|
-5,099
|
-6.40%
|
✓
|
$410.8K |
| Aug 16, 2021 |
Aug 18, 2021 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
7.5
|
-5,628
|
-26.50%
|
✓
|
$504.4K |
| Feb 5, 2021 |
Feb 9, 2021 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
30.0
|
-5,079
|
-6.36%
|
✓
|
$591.1K |
| Jan 25, 2021 |
Jan 27, 2021 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
26.3
|
-5,477
|
-7.80%
|
✓
|
$657.4K |
| Nov 12, 2020 |
Nov 16, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
25.0
|
-2,257
|
-11.48%
|
✓
|
$204.7K |
| Nov 2, 2020 |
Nov 4, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
5.0
|
-20,595
|
-57.26%
|
✓
|
$2M |
| Aug 5, 2020 |
Aug 7, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
22.5
|
-2,257
|
-12.80%
|
✓
|
$268.3K |
| Apr 24, 2020 |
Apr 28, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
25.0
|
-1,934
|
-12.66%
|
✓
|
$192.3K |
| Apr 15, 2020 |
Apr 17, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
7.5
|
-8,632
|
-42.66%
|
✓
|
$817K |
| Feb 7, 2020 |
Feb 11, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
28.8
|
-2,030
|
-9.18%
|
✓
|
$209.7K |
| Feb 5, 2020 |
Feb 7, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
30.0
|
-3,349
|
-6.10%
|
✓
|
$342.9K |
| Jul 15, 2019 |
Jul 17, 2019 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
7.5
|
-5,835
|
-28.13%
|
✓
|
$510.2K |
| Feb 6, 2019 |
Feb 8, 2019 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
37.5
|
-920
|
-4.25%
|
✓
|
$76.9K |
| Feb 5, 2019 |
Feb 6, 2019 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
37.5
|
-1,357
|
-3.57%
|
✓
|
$119.4K |
| Jun 1, 2018 |
Jun 5, 2018 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
5.0
|
-12,350
|
-42.53%
|
✓
|
$1.2M |
| Feb 5, 2018 |
Feb 7, 2018 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
15.0
|
-1,737
|
-20.14%
|
✓
|
$143.8K |
| Feb 6, 2017 |
Feb 8, 2017 |
NEUROCRINE BIOSCIENCES INC
|
Chief Commercial Officer |
Sell |
13.8
|
-953
|
-43.82%
|
✓
|
$41.3K |